A single dose of intravenous combretastatin A4-phosphate is reasonably well tolerated and significantly reduces tumour vascularization in canine spontaneous cancers
2018 ◽
Vol 16
(4)
◽
pp. 467-477
◽
2018 ◽
Vol 31
(4)
◽
pp. 307-313
◽
Keyword(s):
2011 ◽
Vol 71
(6)
◽
pp. 860-870
◽
1981 ◽
Vol 39
◽
pp. 582-583
Keyword(s):
1999 ◽
Vol 66
(6)
◽
pp. 625-635
2008 ◽
Vol 2008
◽
pp. 88
2001 ◽
Vol 88
(2)
◽
pp. 59-66
◽
Keyword(s):
Keyword(s):